CBIO · Crescent Biopharma, Inc.

$16.73 +0.50 (+3.08%)

Market Cap

$602.85M

37.14M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-07-30	—
10-Q	2026-07-30	2026-06-30
8-K	2026-07-15	2026-07-14
8-K	2026-07-14	—
10-Q/A	2026-06-22	2026-03-31
Investor Event Transcript	2026-06-08	2026-06-30
8-K	2026-06-03	2026-06-02
Investor Event Transcript	2026-06-03	2026-06-30
10-Q	2026-04-29	2026-03-31
8-K	2026-04-29	—
DEF 14A	2026-04-21	2026-06-02
10-K	2026-02-26	2025-12-31
8-K	2026-02-26	—
8-K	2025-12-04	2025-12-02
10-Q	2025-11-06	2025-09-30
8-K	2025-11-06	—
10-Q	2025-07-31	2025-06-30
8-K	2025-07-31	2025-07-29
8-K	2025-06-18	2025-06-13
8-K	2025-06-06	2025-06-05
8-K	2025-05-30	—
10-Q	2025-05-14	2025-03-31
8-K	2025-04-29	2025-04-28
8-K	2025-02-25	2025-02-19
8-K	2025-02-14	—
10-K	2025-02-13	2024-12-31
8-K	2025-01-31	2025-01-29
8-K	2025-01-13	—
8-K	2024-12-26	2024-12-19
10-Q	2024-11-13	2024-09-30
8-K	2024-11-07	—
8-K	2024-10-29	2024-10-28
10-Q	2024-08-08	2024-06-30
8-K	2024-07-30	2024-07-24
8-K	2024-06-26	2024-06-21
8-K	2024-06-13	2024-06-10
8-K	2024-06-04	—
10-Q	2024-05-09	2024-03-31
8-K	2024-05-06	—
8-K	2024-05-02	2024-05-01
DEF 14A	2024-04-01	2024-05-01
8-K	2024-03-27	—
10-K	2024-03-27	2023-12-31
8-K	2024-03-01	—
8-K	2024-01-02	—
10-Q	2023-11-03	2023-09-30
8-K	2023-11-03	—
8-K	2023-08-02	—
10-Q	2023-08-02	2023-06-30
8-K	2023-05-22	2023-05-19

Showing 1–50 of 96 filings

Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 77 filings 77 filers Visit website Investor relations